Deals
Teva Jumps to Highest Since 2011 Amid Actavis Acquisition
This article is for subscribers only.
Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, rallied in New York on prospects the company will benefit from the busiest year for health-care acquisitions since 2009.
Shares of Petach Tikva, Israel-based Teva added 2.3 percent to $46.74, the highest since July 2011. The shares increased 17 percent this year. The Bloomberg Israel-US Equity Index of the largest Israeli companies traded in New York retreated 0.6 percent.